Envíos recentes

Mostrando ítems 1266-1270 de 11841

A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-?5 NAM (basmisanil) on intellectual disability associated with Down syndrome

2022- Goeldner, C.; Kishnani, P.S.; Skotko, B.G.; Casero, J.L.; Hipp, J.F.; [et al.]
Nasal Intermittent Positive Pressure Ventilation and Bronchopulmonary Dysplasia Among Very Preterm Infants Never Intubated During the First Neonatal Admission: A Multicenter Cohort Study

2022- Ávila Álvarez, Alejandro; García-Muñoz Rodrigo, F.; Solís-García, G.; Pértega Díaz, Sonia; Sánchez Luna, M.; [et al.]
Aging of glucose profiles in an adult population without diabetes

2022- Pazos Couselo, Marcos; Portos-Regueiro, C.; González-Rodríguez, M.; Manuel García-Lopez, J.; Alonso-Sampredro, M.; [et al.]
Neumonía eosinofílica crónica secundaria a levetiracetam

2022- Pazos Area, Luis Alberto; Ramos Hernández, Cristina; Núñez Fernández, Marta; Gonzalez Montaos, Almudena; Fernández Villar, José Alberto [et al.]
Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning

2022- Queiro, R.; Seoane-Mato, D.; Laiz, A.; Galindez Agirregoikoa, E.; Montilla, C.; [et al.]